GlycanAge
Measure your real health. Predict your future health. Discover your bio-age with a test backed by 300+ research studies
Measure your real health. Predict your future health. Discover your bio-age with a test backed by 300+ research studies
GlycanAge is a biotechnology startup founded in 2020, headquartered in the United Kingdom. The company's slogan, "Measure your real health. Predict your future health. Discover your bio-age with a test backed by 300+ research studies," encapsulates its primary focus.
The company offers a ground-breaking test that analyzes an individual's glycobiology to ascertain their biological age, a significant factor often overlooked in the assessment of one's health. This innovative test not only provides insight into the current state of health but also empowers individuals to make informed decisions regarding lifestyle choices and changes. Only about 54% of biological aging is determined by genes, with the remaining 46% influenced by environmental factors.
One notable milestone in GlycanAge's journey is its recent $4.20M Seed Round investment on 19 February 2024. The investment was led by Kadmos Capital Ltd and LAUNCHub Ventures, signaling confidence from prominent investors in the company's vision and potential within the biotechnology and healthcare industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $4.20M | 2 |
|
19 Feb 2024 |
| Seed Round | Unknown | 1 |
|
01 Jan 2023 |
| Grant | Unknown | 1 |
|
31 Aug 2022 |
| Angel Round | $500.00K | 5 |
|
10 Nov 2021 |
We care about your data, and we'd love to use cookies make your experience better.
